- Home
- RVMD vs WF Comparison
RVMD vs WF Comparison
Compare RVMD & WF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVMD | WF |
|---|---|---|
| Founded | 2014 | 1899 |
| Country | United States | South Korea |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 16.0B |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | RVMD | WF |
|---|---|---|
| Price | $147.38 | $72.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $128.11 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 116.3K |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.38 |
| Revenue Next Year | $411.49 | $4.24 |
| P/E Ratio | ★ N/A | $9.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.00 | $34.02 |
| 52 Week High | $136.80 | $84.71 |
Technical Indicators
Market Signals| Indicator | RVMD | WF |
|---|---|---|
| Relative Strength Index (RSI) | 86.50 | 62.96 |
| Support Level | $93.39 | $51.38 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.43 | 2.03 |
| MACD | 4.88 | 0.87 |
| Stochastic Oscillator | 98.09 | 93.83 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.